Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
暂无分享,去创建一个
U. Boggi | H. Brenner | M. Büchler | M. Gazouli | B. Schöttker | T. Key | P. Souček | D. Campa | C. Rizzato | F. Canzian | W. Greenhalf | Eithne Costello | J. Neoptolemos | J. Izbicki | O. Palmieri | V. Hlaváč | R. Kaaks | P. Hegyi | M. Nentwich | E. Maiello | F. Tavano | F. Gemignani | S. Landi | G. Capurso | H. V. van Laarhoven | P. Vodicka | L. Archibugi | G. Vanella | C. Dervenis | R. Pezzilli | G. Cavestro | R. Szmola | E. Małecka-Panas | B. Holleczek | G. Theodoropoulos | S. Paiella | C. Pasquali | C. Sperti | D. Basso | T. Hackert | B. Mohelníková-Duchoňová | O. Strobel | Y. Vashist | J. Kupcinskas | V. Katzke | A. Padoan | Cornelia Schroeder | M. Bijlsma | F. Izbéki | I. Papanikolaou | L. Ginocchi | R. Talar-Wojnarowska | A. Szentesi | D. Gioffreda | L. Vodickova | K. Jamroziak | A. Mambrini | A. Ivanauskas | S. Bursi | M. Gentiluomo | O. Obazee | M. Loveček | E. Darvasi | O. Strouhal | A. C. Milanetto | Alice Alessandra Galeotti | J. Kupčinskas | Ofure Obazee | Ondřej Strouhal
[1] D. Campa,et al. Genetic variants in taste-related genes and risk of pancreatic cancer. , 2019, Mutagenesis.
[2] D. Campa,et al. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals. , 2019, Mutagenesis.
[3] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[4] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[5] Peter Kraft,et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.
[6] N. Funel,et al. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study , 2017, International journal of cancer.
[7] W. Willett,et al. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. , 2016, JAMA oncology.
[8] Alison P. Klein,et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 , 2016, Oncotarget.
[9] Krzysztof Jamroziak,et al. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk , 2016, Oncotarget.
[10] L. Amundadottir. Pancreatic Cancer Genetics , 2016, International journal of biological sciences.
[11] N. Funel,et al. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility , 2015, International journal of cancer.
[12] Manal M. Hassan,et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer , 2015, Nature Genetics.
[13] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[14] K. Hemminki,et al. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk , 2015, Scientific Reports.
[15] P. Maisonneuve,et al. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. , 2015, International journal of epidemiology.
[16] H. Frucht,et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. , 2014, World journal of gastroenterology.
[17] Yusuke Nakamura,et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.
[18] Alison P. Klein,et al. An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population , 2013, PloS one.
[19] J. Hoheisel,et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. , 2013, Oncology reports.
[20] Harvey Risch,et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. , 2013, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] N. Funel,et al. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[22] Paul Fockens,et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.
[23] Peter Kraft,et al. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status , 2012, Journal of Medical Genetics.
[24] Bond-Smith Giles,et al. Only women with symptoms need to have their breast implants removed, says government , 2012 .
[25] Peter Kraft,et al. Common Genetic Variants in Prostate Cancer Risk Prediction—Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[26] A. Klein. Genetic susceptibility to pancreatic cancer , 2012, Molecular carcinogenesis.
[27] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[28] Geoffrey S. Tobias,et al. Variant ABO Blood Group Alleles, Secretor Status, and Risk of Pancreatic Cancer: Results from the Pancreatic Cancer Cohort Consortium , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[29] M. Thun,et al. Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .
[30] Wei Zheng,et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.
[31] Geoffrey S. Tobias,et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. , 2010, Cancer research.
[32] Geoffrey S. Tobias,et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.
[33] S. Chanock,et al. ABO blood group and the risk of pancreatic cancer. , 2009, Journal of the National Cancer Institute.
[34] R. Wilkins. Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.
[35] B. Ponder,et al. Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.
[36] Margaret Sullivan Pepe,et al. Estimating the capacity for improvement in risk prediction with a marker. , 2008, Biostatistics.
[37] Peter M Visscher,et al. Prediction of individual genetic risk to disease from genome-wide association studies. , 2007, Genome research.
[38] Ewout W Steyerberg,et al. Predictive testing for complex diseases using multiple genes: Fact or fiction? , 2006, Genetics in Medicine.
[39] N. Lemoine,et al. Pancreatic Cancer Genetics , 2001, Pancreatology.
[40] J. Kleeff,et al. Pancreatic cancer , 1988, Nature Reviews Disease Primers.
[41] D. Marcus. The ABO and Lewis blood-group system. Immunochemistry, genetics and relation to human disease. , 1969, The New England journal of medicine.
[42] I. Gram,et al. An epidemiological model for prediction of endometrial cancer risk in Europe , 2015, European Journal of Epidemiology.
[43] S. Sams,et al. Performance of Common Genetic Variants in Breast-Cancer Risk Models , 2011 .
[44] Wolfgang Schima,et al. Pancreatic adenocarcinoma , 2006, European Radiology.